Skip to content

Author

Vitalii B. Kaliberdenko

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Bortezomib in combination with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma: evaluation of efficacy and safety in real clinical practice

Multiple myeloma (MM) is a common hematological malignancy. The high efficacy of the VTD induction regimen (bortezomib, thalidomide, dexamethasone) is limited by dose-dependent adverse reactions of thalidomide.  Objective. To evaluate the effect of a thalidomide dose-escalation strategy in the VTD regimen on efficac...

J. M. Al-Nsour, Vitalii B. Kaliberdenko, Amina R. Ablaeva et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.